Chargement en cours...

Progress and Challenges Associated with the Development of Ricin Toxin Subunit Vaccines

The past several years have seen major advances in the development of a safe and efficacious ricin toxin vaccine, including the completion of two Phase I clinical trials with two different recombinant A subunit (RTA)-based vaccines: RiVax™ and RVEc™ adsorbed to aluminum salt adjuvant, as well as a n...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Expert Rev Vaccines
Auteurs principaux: Vance, David J., Mantis, Nicholas J.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193006/
https://ncbi.nlm.nih.gov/pubmed/26998662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14760584.2016.1168701
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!